HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Li Selected Research

xiao zhi ling

4/2000[A pharmacological study on suppository for anti-prostatis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Li Research Topics

Disease

315Neoplasms (Cancer)
05/2022 - 01/2000
108Infections
04/2022 - 01/2000
69Neoplasm Metastasis (Metastasis)
05/2022 - 01/2000
60Inflammation (Inflammations)
02/2022 - 01/2000
53Breast Neoplasms (Breast Cancer)
05/2022 - 04/2000
40Hepatocellular Carcinoma (Hepatoma)
01/2020 - 01/2000
35Body Weight (Weight, Body)
08/2022 - 04/2000
32Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 02/2001
30Carcinogenesis
09/2020 - 11/2000
29Hypertension (High Blood Pressure)
01/2022 - 05/2000
29Carcinoma (Carcinomatosis)
11/2021 - 11/2000
28Hemorrhage
02/2022 - 02/2000
28Fibrosis (Cirrhosis)
12/2021 - 10/2001
26Wounds and Injuries (Trauma)
03/2022 - 06/2000
26Hypoxia (Hypoxemia)
10/2021 - 01/2000
25Lung Neoplasms (Lung Cancer)
02/2021 - 04/2000
24Ischemia
02/2020 - 07/2000
24Prostatic Neoplasms (Prostate Cancer)
01/2020 - 04/2005
23Stomach Neoplasms (Stomach Cancer)
05/2022 - 04/2000
23Chronic Hepatitis B
12/2021 - 03/2010
23Asthma (Bronchial Asthma)
07/2021 - 06/2000
22Type 2 Diabetes Mellitus (MODY)
10/2020 - 06/2000
21Necrosis
04/2022 - 01/2000
21Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2000
20Pain (Aches)
01/2022 - 03/2001
19Reperfusion Injury
07/2020 - 07/2000
18Multiple Myeloma
02/2022 - 09/2000
17Cognitive Dysfunction
01/2022 - 09/2004
17Stroke (Strokes)
10/2021 - 05/2000
17Liver Diseases (Liver Disease)
12/2019 - 06/2000
15Sepsis (Septicemia)
12/2021 - 03/2001
15Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2021 - 05/2000
15Atherosclerosis
12/2018 - 08/2000
14Obesity
06/2022 - 06/2000
14Squamous Cell Carcinoma of Head and Neck
03/2022 - 03/2000
14Hyperplasia
08/2021 - 06/2000
14Atrophy
08/2020 - 01/2000
14Insulin Resistance
07/2020 - 02/2000
14Myocardial Infarction
12/2019 - 08/2000
14Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019 - 01/2001
13Osteoarthritis
02/2022 - 02/2001
13Rheumatoid Arthritis
04/2021 - 01/2000
13Lymphatic Metastasis
01/2021 - 04/2000
13Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2001
13Thrombosis (Thrombus)
08/2020 - 10/2000
13Liver Cirrhosis (Hepatic Cirrhosis)
08/2019 - 10/2000
12Pneumonia (Pneumonitis)
04/2022 - 01/2000
12Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2022 - 04/2000
12Hepatitis B
11/2021 - 11/2001
12Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021 - 12/2001
12Leukemia
08/2021 - 05/2000
12Tuberculosis (Tuberculoses)
02/2021 - 11/2001
12Diabetes Mellitus
01/2021 - 04/2001

Drug/Important Bio-Agent (IBA)

149Proteins (Proteins, Gene)FDA Link
04/2022 - 01/2000
68Messenger RNA (mRNA)IBA
04/2022 - 03/2000
51Biomarkers (Surrogate Marker)IBA
05/2022 - 09/2004
44Pharmaceutical PreparationsIBA
03/2022 - 01/2000
39CytokinesIBA
03/2022 - 02/2000
38DNA (Deoxyribonucleic Acid)IBA
08/2021 - 03/2000
35MicroRNAs (MicroRNA)IBA
04/2022 - 10/2011
33Glucose (Dextrose)FDA LinkGeneric
02/2022 - 09/2001
33EnzymesIBA
01/2022 - 01/2000
32Biological ProductsIBA
01/2022 - 01/2008
29AntigensIBA
02/2021 - 01/2000
25Therapeutic UsesIBA
09/2020 - 01/2000
24Long Noncoding RNAIBA
01/2022 - 11/2014
21Indicators and Reagents (Reagents)IBA
01/2022 - 06/2000
20VaccinesIBA
04/2022 - 07/2001
20Insulin (Novolin)FDA Link
01/2021 - 02/2000
20Anti-Bacterial Agents (Antibiotics)IBA
11/2019 - 06/2000
19RNA (Ribonucleic Acid)IBA
12/2021 - 01/2000
17Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 06/2000
17Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2021 - 02/2000
17Cisplatin (Platino)FDA LinkGeneric
01/2020 - 03/2000
16CholesterolIBA
10/2021 - 06/2000
15LipidsIBA
08/2022 - 04/2000
15AlbuminsIBA
02/2022 - 08/2000
15Monoclonal AntibodiesIBA
08/2019 - 05/2000
14Phosphotransferases (Kinase)IBA
10/2021 - 06/2000
14ErbB Receptors (EGF Receptor)IBA
09/2021 - 01/2001
14Small Interfering RNA (siRNA)IBA
03/2019 - 05/2008
13GlucocorticoidsIBA
04/2022 - 09/2000
13AutoantibodiesIBA
02/2022 - 07/2001
13Triglycerides (Triacylglycerol)IBA
10/2021 - 06/2000
13AntibodiesIBA
04/2021 - 06/2000
13Interleukin-6 (Interleukin 6)IBA
01/2021 - 08/2001
13Peptides (Polypeptides)IBA
01/2016 - 01/2000
12C-Reactive ProteinIBA
02/2022 - 08/2008
12Antiviral Agents (Antivirals)IBA
12/2021 - 01/2000
12Hormones (Hormone)IBA
05/2021 - 02/2000
12Adenosine Triphosphate (ATP)IBA
12/2019 - 03/2001

Therapy/Procedure

196Therapeutics
03/2022 - 05/2000
60Drug Therapy (Chemotherapy)
01/2021 - 01/2000
32Transplantation
09/2019 - 02/2000
31Radiotherapy
02/2022 - 08/2000
18Liver Transplantation
01/2021 - 08/2001
16Aftercare (After-Treatment)
08/2021 - 01/2000
14Length of Stay
04/2022 - 01/2013
13Lasers (Laser)
06/2021 - 09/2000
12Immunotherapy
04/2022 - 01/2000